Gilman Hill Asset Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Gilman Hill Asset Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-116	Closed	–	–	157
2013 Q4	$0	Buy	+116	New	+$140	﹤0.01%	139
2013 Q3	–	Sell	-116	Closed	–	–	128
2013 Q2	$0	Buy	+116	New	+$204	﹤0.01%	121

Other funds holding GCVRZ

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Allianz Asset Management

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gilman Hill Asset Management's GCVRZ Position: Q1 2014 in Review

Gilman Hill Asset Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2014, closing a stake of 116 shares.

Gilman Hill Asset Management first reported a position in GCVRZ in Q2 2013 and held it in 2 quarters. The position peaked at $0 in Q4 2013. 125 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2014.

Gilman Hill Asset Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2014 after selling out during the quarter.
Gilman Hill Asset Management sold 116 Sanofi Contingent Value Rights shares in Q1 2014.
Gilman Hill Asset Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 2 quarters.
Gilman Hill Asset Management's Sanofi Contingent Value Rights position peaked at $0 in Q4 2013.
125 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2014.

Based on Gilman Hill Asset Management's 13F filing for Q1 2014, filed 23 Apr 2014.